Abstract

The invention relates to the use of metronidasole for preparing a pharmaceutical composition for treating pathologies involving at least one B-type receptor selected in a group containing an IL-8RB receptor and a PAC-1 receptor.


Claims

Information currently unavailable.

Download PDF
Document Preview
Document History
  • Publication: May 4, 2006
  • Application: Feb 17, 2005
    WO FR 2005000370 W
  • Priority: Feb 20, 2004
    FR FR 0401721 A

Sign in to the Lens